Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aquaporin-7 is a membrane transporter of the aquaporin family that primarily facilitates glycerol transport across the plasma membrane of adipocytes and other tissues such as testis, kidney, and muscle[1][2]. It enables the rapid, selective movement of glycerol, water, and urea, and is crucial for lipid and energy metabolism. The AQP7 channel's function is tightly regulated—hormonally controlled trafficking modulates its localization between lipid droplets and the plasma membrane in adipocytes, supporting the release of glycerol during lipolysis and influencing fat storage/mobilization dynamics[1]. AQP7 dysfunction or altered expression is linked to several metabolic diseases, notably obesity and diabetes, and is being investigated as a potential therapeutic target. Its unique structure includes areas devoted to both water and glycerol selectivity, distinguishing it from "orthodox" aquaporins, which transport exclusively water[1][2][3].
Inhibitors or modulators would act by altering glycerol and/or water permeability across adipocyte and other cell membranes, potentially affecting adipose tissue metabolism and systemic lipid/glucose homeostasis[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aquaporin-7 (AQP7).